SEC 13F Intelligence

Canada Life Assurance Co / VRTX

Canada Life Assurance Co’s Vertex Pharmaceuticals Inc Position

Does Canada Life Assurance Co own Vertex Pharmaceuticals Inc (VRTX)? Yes192.1K shares worth $86M (+0.15% of its 13F portfolio) as of Q1 2026, up from 187.6K shares the prior filed quarter.

Position Value
$86M
Q1 2026
Shares
192.1K
% of Portfolio
+0.15%
Quarters Held
29
currently held

Position History VRTX

Reported value by quarter
Q1 ’19: $40MQ1 ’19Q2 ’19: $42MQ3 ’19: $38MQ4 ’19: $59MQ1 ’20: $63MQ1 ’20Q2 ’20: $84MQ3 ’20: $86MQ4 ’20: $80MQ1 ’21: $61MQ1 ’21Q2 ’21: $78MQ3 ’21: $71MQ4 ’21: $89MQ1 ’22: $110MQ1 ’22Q2 ’22: $84MQ3 ’22: $86MQ4 ’22: $81MQ1 ’23: $86MQ1 ’23Q2 ’23: $99MQ3 ’23: $99MQ4 ’23: $113MQ1 ’24: $113MQ1 ’24Q2 ’24: $150MQ3 ’24: $148MQ4 ’24: $109MQ1 ’25: $131MQ1 ’25Q2 ’25: $121MQ3 ’25: $108MQ4 ’25: $85MQ1 ’26: $86MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026192.1K$86M+0.15%
Q4 2025187.6K$85M+0.15%
Q3 2025274.1K$108M+0.16%
Q2 2025270.7K$121M+0.19%
Q1 2025270.7K$131M+0.23%
Q4 2024269.9K$109M+0.19%
Q3 2024318.3K$148M+0.26%
Q2 2024320.3K$150M+0.28%
Q1 2024270.2K$113M+0.23%
Q4 2023278.5K$113M+0.25%
Q3 2023283.6K$99M+0.24%
Q2 2023280.8K$99M+0.24%
Q1 2023273.7K$86M+0.21%
Q4 2022278.3K$81M+0.21%
Q3 2022298.2K$86M+0.25%
Q2 2022299.5K$84M+0.22%
Q1 2022400.3K$110M+0.23%
Q4 2021405.6K$89M+0.18%
Q3 2021389.6K$71M+0.17%
Q2 2021388.6K$78M+0.18%
Q1 2021285.1K$61M+0.15%
Q4 2020338.4K$80M+0.15%
Q3 2020315.0K$86M+0.19%
Q2 2020289.5K$84M+0.19%
Q1 2020263.7K$63M+0.17%
Q4 2019272.5K$59M+0.13%
Q3 2019225.3K$38M+0.09%
Q2 2019228.6K$42M+0.10%
Q1 2019218.4K$40M+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Canada Life Assurance Co’s full portfolio or all institutional holders of VRTX.